Literature DB >> 7961581

Brain region effects of clozapine on amino acid and monoamine transmission.

B K Yamamoto1, E A Pehek, H Y Meltzer.   

Abstract

The purpose of the study was to compare the effects of clozapine and haloperidol on monoamine and amino acid transmission in limbic and extrapyramidal brain regions of the rat. In vivo microdialysis was used to measure the concentrations of neurotransmitters after acute and chronic drug administration. The acute administration of clozapine increased dopamine and glutamate in the medial prefrontal cortex and produced a greater increase, compared with haloperidol, in GABA (gamma-aminobutyric acid) efflux within the ventral pallidum. Chronic treatment with clozapine increased dopamine and serotonin in the medial prefrontal cortex. Chronic haloperidol administration increased glutamate in the striatum by fivefold whereas chronic clozapine treatment had no effect on striatal glutamate. Furthermore, chronic haloperidol administration transiently increased, then decreased, GABA efflux in the substantia nigra. Overall, clozapine has a preferential effect on mesocorticolimbic neurotransmission whereas haloperidol alters glutamate and GABA efflux within the extrapyramidal motor system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961581

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

1.  Cognition, schizophrenia, and the atypical antipsychotic drugs.

Authors:  H Y Meltzer; S Park; R Kessler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Differential effects of clozapine and haloperidol on interval timing in the supraseconds range.

Authors:  Christopher J MacDonald; Warren H Meck
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

Review 3.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

4.  5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA.

Authors:  Mei Huang; Sunoh Kwon; Lakshmi Rajagopal; Wenqi He; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2018-07-31       Impact factor: 4.530

5.  Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  Biol Psychiatry       Date:  2006-10-13       Impact factor: 13.382

Review 6.  N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives.

Authors:  Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2005-03-10       Impact factor: 4.530

7.  The novel α7 nicotinic acetylcholine receptor agonist EVP-6124 enhances dopamine, acetylcholine, and glutamate efflux in rat cortex and nucleus accumbens.

Authors:  Mei Huang; Anna R Felix; Dorothy G Flood; Chaya Bhuvaneswaran; Dana Hilt; Gerhard Koenig; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2014-05-09       Impact factor: 4.530

8.  Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration.

Authors:  Wendy H Fasulo; Scott E Hemby
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

9.  Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC.

Authors:  Marta Baviera; Roberto W Invernizzi; Mirjana Carli
Journal:  Psychopharmacology (Berl)       Date:  2007-10-17       Impact factor: 4.530

10.  Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement.

Authors:  Vicente Molina; Juan D Gispert; Santiago Reig; Javier Sanz; Javier Pascau; Andrés Santos; Manuel Desco; Tomás Palomo
Journal:  Psychopharmacology (Berl)       Date:  2004-09-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.